Literature DB >> 16124061

Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumor.

Ge Lou1, Ying Gao, Xiao-Ming Ning, Qi-Fan Zhang.   

Abstract

AIM: To explore the expression and correlation of CD44v6, vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2 and matrix metalloproteinase (MMP)-9 in Krukenberg and primary epithelial ovarian carcinoma.
METHODS: The expressions of CD44v6, VEGF, MMP-2 and MMP-9 were detected by immunohistochemical method in 20 cases of normal ovarian tissues, 38 cases of Krukenberg tumor and 45 cases of primary epithelial ovarian carcinoma.
RESULTS: The expression of CD44v6 (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: chi(2) = 4.516, P = 0.034; Krukenberg tumor tissue vs normal ovarian tissue: chi(2) = 19.537, P = 0.001) and VEGF (primary epithelial ovarian carcinoma tissue vs normal ovarian tissue: P = 0.026; Krukenberg tumor tissue vs normal ovarian tissue: chi(2) = 22.895, P = 0.001) was significantly higher in primary epithelial ovarian carcinoma tissue and Krukenberg tumor tissue than in normal ovarian tissue. The positive expression rate of MMP-2 and MMP-9 was 0% in the normal ovarian tissue. The positive expression rate of CD44v6 (chi(2) = 10.398, P = 0.001), VEGF (chi(2) = 13.149, P = 0.001), MMP-2 (chi(2) = 33.668, P = 0.001) and MMP-9 (chi(2) = 38.839, P = 0.001) was remarkably higher in Krukenberg tumor than in primary epithelial ovarian carcinoma. The correlation of CD44v6, VEGF, MMP-2, and MMP-9 was observed in primary epithelial ovarian carcinoma and Krukenberg tumor.
CONCLUSION: CD44v6, VEGF, MMP-2, and MMP-9 are involved in ovarian carcinoma, gastric cancer and Krukenberg tumor. Detection of CD44v6, VEGF, MMP-2 and MMP-9 may contribute to the diagnosis of ovarian carcinoma, gastric cancer, and Krukenberg tumor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16124061      PMCID: PMC4321925          DOI: 10.3748/wjg.v11.i32.5032

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Relationship between biologic behavior and phenotypic expression in intramucosal gastric carcinomas.

Authors:  Akira Kabashima; Takashi Yao; Keizo Sugimachi; Masazumi Tsuneyoshi
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

2.  Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.

Authors:  Chunyuan Yu; Kaifeng Pan; Deyin Xing; Gang Liang; Wen Tan; Lian Zhang; Dongxin Lin
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

3.  Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.

Authors:  Akio Yamaguchi; Takanori Goi; Jiren Yu; Yasuo Hirono; Makoto Ishida; Atsushi Iida; Toshihisa Kimura; Kazuo Takeuchi; Kanji Katayama; Kazuo Hirose
Journal:  J Surg Oncol       Date:  2002-04       Impact factor: 3.454

4.  A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.

Authors:  Angelo Vacca; Roberto Ria; Domenico Ribatti; Fabrizio Semeraro; Valentin Djonov; Francesco Di Raimondo; Franco Dammacco
Journal:  Haematologica       Date:  2003-02       Impact factor: 9.941

5.  Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.

Authors:  Yoshito Matsuyama; Sonshin Takao; Takashi Aikou
Journal:  J Surg Oncol       Date:  2002-06       Impact factor: 3.454

6.  [Roles of VEGF-C and its receptor Flt-4 in proliferation and metastasis of primary breast cancer].

Authors:  Fang Liu; Ya-Jie Zhang
Journal:  Ai Zheng       Date:  2003-10

Review 7.  Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

Authors:  Napoleone Ferrara
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

8.  Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.

Authors:  Barbro K Linderholm; Birgitta Lindh; Lars Beckman; Martin Erlanson; Kent Edin; Bjorn Travelin; Jonas Bergh; Kjell Grankvist; Roger Henriksson
Journal:  Clin Breast Cancer       Date:  2003-12       Impact factor: 3.225

9.  Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma.

Authors:  Yutaka Takahashi; Yasuhiko Kitadai; Lee M Ellis; Corazon D Bucana; Isaiah J Fidler; Masayoshi Mai
Journal:  Jpn J Cancer Res       Date:  2002-11

10.  Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

Authors:  E T Waas; R M L M Lomme; J DeGroot; Th Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more
  3 in total

1.  Prognostic significance of vascular endothelial growth factor expression in gastric carcinoma: a meta-analysis.

Authors:  Jing Chen; Tao Li; Yuanyuan Wu; Lijun He; Li Zhang; Tieliu Shi; Zhengfang Yi; Mingyao Liu; Xiufeng Pang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-15       Impact factor: 4.553

2.  Effects of LY294002 on the invasiveness of human gastric cancer in vivo in nude mice.

Authors:  Chun-Gen Xing; Bao-Song Zhu; Xiao-Qing Fan; Hui-Hui Liu; Xun Hou; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

3.  Blockade of NF-κB nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells.

Authors:  Zhi-Min Li; Yu-Wei Pu; Bao-Song Zhu
Journal:  Oncol Lett       Date:  2013-06-11       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.